(p <0,0001)
(3,9 - 10,00 mmol/L) from 11,7 to 16,8 hours per day with increased scanning frequency37
(p<0,001)
across patients with T1D and T2D37
(p<0,001)
in patients with T2D17
(p<0,0006)
Have a better understaning of their glucose fluctuations40
(>10 mmol/L) by 1 hr/day with no significant increase in time spent in hypoglycemia (<3.9 mmol/L)27
The FreeStyle portfolio helps patients learn and understand the three key areas for improving their diabetes treatment
Explore our training resources to help you to help your patients understand Time in Range better.
See our webinars for Healthcare Professionals
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
15. For children aged 4-12, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre system and interpreting its readings.
17. Haak, Thomas., et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, openlabel randomized controlled trial. DiabetesTherapy 8.1 (2017): 55–73..
20. Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestjin, Jens Kröger, Raimund Weitgasser. “Novel Glucose-Sensing Technology and Hypoglycaemia in Type 1 Diabetes: a Multicentre, Non-Masked, Randomised Controlled Trial.” Lancet 388, no. 10057 (2016): 2254–2263. https://doi.org/10.1016/S0140-6736(16)31535-5.
27. Campbell FM, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes 2018;19(7):1294–301.
36. Dunn, T., et al. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests. Diabetes Research and Clinical Practice; 137(2018) 37-46
37. Lang J, et al. Expanded real-world use confirms strong association between frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes 2019 Jun; 68(Supplement 1). https://doi.org/10.2337/db19- 972-P.
38. Kröger J, et al. Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with type 2 diabetes. Diabetes Ther 2020;11(1):279–91.
39. Yaron M, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care 2019;42(7):1178–84.
40. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809
ADC-92113 v1 08/24
Lenken "Ja" nedenfor tar deg til et nettsted som ikke tilhører Abbott Laboratories. Lenker til andre nettsteder er ikke under kontroll av Abbott Laboratories, og Abbott Laboratories er ikke ansvarlig for innholdet på slike nettsteder eller noen lenker på slike nettsteder. Abbott Laboratories gir disse lenkene til deg kun som en bekvemmelighet, og inkluderingen av en lenke innebærer ikke at Abbott Laboratories godkjenner nettstedet.
Vil du forlate denne siden?
Dette er et produktspesifikt nettsted kun beregnet for helsepersonell i Norge. Hvis du bor i et annet land, kontakt ditt lokale Abbott-kontor for å få riktig produktinformasjon for ditt land.
Tar deg til pasientsiden
Tar deg til helsepersonellsiden
HOLD DEG OPPDATERT